Table 2.

Correlation between clinicopathological features and PLR, HPR, CEA in rectal cancer

	N	PLR	P	HPR	P	CEA	P
Gender
Male	140	130.89 (96.00, 171.23)	.770	0.55 (0.44, 0.64)	.000	2.86 (1.68, 4.53)	.506
Female	95	128.16 (103.75, 175.37)		0.47 (0.38, 0.55)		2.74 (1.45, 4.83)
Tumor invasion (T stage)
T1 + T2	101	121.29 (93.18, 160.96)	.064	0.52 (0.44, 0.61)	.055	2.66 (1.68, 3.90)	.047
T3 + T4	134	134.80 (98.82,185.33)		0.48 (0.38, 0.59)		3.06 (1.57, 5.91)
Lymph node metastasis (N stage)
N0	146	125.16 (96.13, 160.30)	.036	0.52 (0.44, 0.63)	.010	2.74 (1.57, 4.25)	0.359
N1‐N3	89	141.78 (98.24, 196.68)		0.47 (0.37, 0.57)		2.95 (1.64, 5.60)
Distant metastasis (M stage)
M0	231	129.56 (96.60, 171.23)		0.51 (0.42, 0.60)		2.79 (1.59, 4.56)
M1	4	167.18 (92.50, 286.05)		0.43 (0.29, 0.69)		5.14 (1.75, 10.53)
Tumor size (cm)
<5	128	127.80 (96.34, 161.69)	.398	0.51 (0.43, 0.61)	.108	2.62 (1.54, 3.95)	.021
≥5	107	130.83 (98.35, 195.03)		0.50 (0.38, 0.58)		3.18 (1.67, 6.52)
Stage
I + II	161	123.87 (94.50, 160.96)	.005	0.53 (0.44, 0.61)	.000	2.74 (1.60, 4.26)	.317
III + IV	74	147.30 (108.62, 209.56)		0.45 (0.37, 0.57)		3.07 (1.57, 5.66)